ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
Neuroscience Letters
Volume 335, Issue 1, 19 December 2002, Pages 25-28
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (147 K)

Article Toolbox
 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/S0304-3940(02)01158-8    
How to Cite or Link Using DOI (Opens New Window)

Copyright © 2002 Elsevier Science Ireland Ltd. All rights reserved.

Zinc potentiates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced dopamine depletion in caudate nucleus of mice brain

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Saber HussainCorresponding Author Contact Information, E-mail The Corresponding Author, a and Syed F. Alia, b

a Neurochemistry Laboratory, Division of Neurotoxicology, National Center for Toxicological Research/FDA, Jefferson, AR 72079, USA

b Department of Biochemistry and Molecular Biology and Neurology, University of Arkansas for Medical Sciences, Little Rock, AR 722, USA


Received 26 June 2002; 
revised 27 September 2002; 
accepted 2 October 2002. ;
Available online 15 November 2002.

Abstract

Present study describes the effect of zinc (Zn) on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced dopamine depletion in mice brain. MPTP is a known neurotoxicant primarily causing marked depletion of dopamine (DA) levels in nigrostriatal dopaminergic system. Adult Male C57-mice were intraperitonially injected with 25 mg/kg MPTP in the presence or absence of zinc acetate. Twenty-four hours after treatment animals were sacrificed and DA levels were determined by high performance liquid chromatography in caudate nucleus of control and treated mice. The results showed that there was a marked depletion of DA in MPTP treated mice, whereas no change was observed in DA levels in mice treated with Zn when compare to controls. Interestingly, mice receiving MPTP in conjunction with Zn showed significantly lower DA levels in brain when compare to animals receiving MPTP alone. In summary the data suggest that Zn treatment potentiates depletion of dopamine in MPTP treated mice.

Author Keywords: 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Zinc; Dopamine; Mice

Article Outline

• Acknowledgements
• References


Corresponding Author Contact Information Corresponding author. Mantech Environmental Technology, Air Force Research Laboratory, P.O. Box 31009, Dayton, OH-45431, USA. Tel.: +1-937-255-5150 ext. 3113; fax: +1-937-258-2197; email: saber.hussain@wpafb.af.mil


Neuroscience Letters
Volume 335, Issue 1, 19 December 2002, Pages 25-28
 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2009 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.